MONICA SHAMBO: Open Payments
NPI 1033709068 · FAIRHOPE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,374 in 59 payments from 15 companies in 2025. Trend: 2023 $939 · 2024 $1,291 · 2025 $1,374
Food & beverage: $1,374
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 12 | $289 |
| Janssen Biotech, Inc. | 7 | $282 |
| ABBVIE INC. | 17 | $274 |
| UROGEN PHARMA, INC. | 4 | $132 |
| IMMUNITYBIO, INC. | 4 | $104 |
| Olympus America Inc. | 2 | $50 |
| Medtronic, Inc. | 2 | $45 |
| Endo USA, Inc. | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| PFIZER INC. | 2 | $36 |
Products named: BOTOX, GEMTESA, RYBREVANT, ERLEADA, ANKTIVA, iTIND System, PLUVICTO, XTANDI.
Industry payments across AL — which companies pay providers there.
